{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:50:59Z","timestamp":1793213459912,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C26642\/A27963"],"award-info":[{"award-number":["C26642\/A27963"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81401990"],"award-info":[{"award-number":["81401990"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"publisher","award":["259204"],"award-info":[{"award-number":["259204"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ebiom.2021.103547","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T23:49:17Z","timestamp":1630367357000},"page":"103547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Automated assessment of CD8+ T-lymphocytes and stroma fractions complement conventional staging of colorectal cancer"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9187-7152","authenticated-orcid":false,"given":"Dan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarjei S.","family":"Hveem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Glaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Church","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7811-6722","authenticated-orcid":false,"given":"David J.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5vard E.","family":"Danielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ebiom.2021.103547_bib0001","first-page":"145","article-title":"Colorectal cancer statistics","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103547_bib0002","first-page":"93","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103547_bib0003","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/0284186X.2014.975839","article-title":"Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature","volume":"54","author":"Bockelman","year":"2015","journal-title":"Acta Oncol"},{"issue":"16","key":"10.1016\/j.ebiom.2021.103547_bib0004","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1200\/JCO.2004.05.063","article-title":"American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer","volume":"22","author":"Benson","year":"2004","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103547_bib0005","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"issue":"10135","key":"10.1016\/j.ebiom.2021.103547_bib0006","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pag\u00e8s","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103547_bib0007","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/annonc\/mds246","article-title":"The proportion of tumor-stroma as a strong prognosticator for stages II and III colon cancer patients: validation in the VICTOR trial","volume":"24","author":"Huijbers","year":"2013","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103547_bib0008","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/annonc\/mdt593","article-title":"The relationship between tumor stroma percentage, the tumor microenvironment and survival in patients with primary operable colorectal cancer","volume":"25","author":"Park","year":"2014","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103547_bib0009","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S1470-2045(16)30172-3","article-title":"Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomized phase 3 trial","volume":"17","author":"Kerr","year":"2016","journal-title":"Lancet Oncol"},{"issue":"30","key":"10.1016\/j.ebiom.2021.103547_bib0010","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1200\/JCO.2010.29.6244","article-title":"Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial","volume":"28","author":"Midgley","year":"2010","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103547_bib0011","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41416-019-0540-4","article-title":"Tumor-infiltrating CD8(+) lymphocytes and colorectal cancer recurrence by tumor and nodal stage","volume":"121","author":"Glaire","year":"2019","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103547_bib0012","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/his.12624","article-title":"Computerized image analysis of the Ki-67 proliferation index in mantle cell lymphoma","volume":"67","author":"Blaker","year":"2015","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103547_bib0013","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/annonc\/mdx794","article-title":"Prognostic markers for colorectal cancer: estimating ploidy and stroma","volume":"29","author":"Danielsen","year":"2018","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103547_bib0014","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1109\/TCE.2006.1649677","article-title":"Robust automatic white balance algorithm using gray color points in images","volume":"52","author":"Huo","year":"2006","journal-title":"IEEE Trans Consum Electron"},{"key":"10.1016\/j.ebiom.2021.103547_bib0015","series-title":"Proceedings of the IEEE International Symposium on Biomedical Imaging: From Nano to Macro","first-page":"1107","article-title":"A method for normalizing histology slides for quantitative analysis","author":"Macenko","year":"2009"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103547_bib0016","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1109\/TSMC.1979.4310076","article-title":"A threshold selection method from gray-level histograms","volume":"9","author":"Otsu","year":"1979","journal-title":"IEEE Trans Syst Man Cybern"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103547_bib0017","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S2468-1253(18)30117-1","article-title":"Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series","volume":"3","author":"Domingo","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"13","key":"10.1016\/j.ebiom.2021.103547_bib0018","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMoa1713709","article-title":"Duration of adjuvant chemotherapy for stage III colon cancer","volume":"378","author":"Grothey","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2021.103547_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00241","article-title":"Transcriptional subtyping and CD8 immunohistochemistry identifies patients with stage II and III colorectal cancer with poor prognosis who benefit from adjuvant chemotherapy","volume":"2","author":"Allen","year":"2018","journal-title":"JCO Precis Oncol"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103547_bib0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/cjp2.171","article-title":"Histological phenotypic subtypes predict recurrence risk and response to adjuvant chemotherapy in patients with stage III colorectal cancer","volume":"6","author":"Roseweir","year":"2020","journal-title":"J Pathol Clin Res"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103547_bib0021","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1158\/1078-0432.CCR-11-1469","article-title":"Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications","volume":"18","author":"Sinicrope","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103547_bib0022","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.4287","article-title":"Towards the introduction of the 'immunoscore' in the classification of malignant tumors","volume":"232","author":"Galon","year":"2014","journal-title":"J Pathol"},{"key":"10.1016\/j.ebiom.2021.103547_bib0023","doi-asserted-by":"crossref","first-page":"15095","DOI":"10.1038\/ncomms15095","article-title":"Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer","volume":"8","author":"Carstens","year":"2017","journal-title":"Nat Commun"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421003406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421003406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:33:49Z","timestamp":1778873629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396421003406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":23,"alternative-id":["S2352396421003406"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103547","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Automated assessment of CD8+ T-lymphocytes and stroma fractions complement conventional staging of colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103547","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103547"}}